Yuzuriha Akinori

Research theme for competitive and other funds (2)：

Papers (10)：

Si Jing Chen, Kazuya Hashimoto, Kosuke Fujio, Karin Hayashi, Sudip Kumar Paul, Akinori Yuzuriha, Wei-Yin Qiu, Emiri Nakamura, Maria Alejandra Kanashiro, Mio Kabata, et al. A let-7 microRNA-RALB axis links the immune properties of iPSC-derived megakaryocytes with platelet producibility. Nature Communications. 2024
Charlotte Flahou, Tatsuya Morishima, Natsumi Higashi, Yoshikazu Hayashi, Huaigeng Xu, Bo Wang, Chaoqi Zhang, Atsushi Ninomiya, Wei-Yin Qiu, Akinori Yuzuriha, et al. Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells. Biochemical and biophysical research communications. 2023. 662. 76-83
Akinori Yuzuriha, Koji Eto. Revised "hPSC-Sac Method" for Simple and Efficient Differentiation of Human Pluripotent Stem Cells to Hematopoietic Progenitor Cells. Methods in molecular biology (Clifton, N.J.). 2021
Akinori Yuzuriha, Sou Nakamura, Naoshi Sugimoto, Shunsuke Kihara, Masato Nakagawa, Takuya Yamamoto, Kiyotoshi Sekiguchi, Koji Eto. Extracellular laminin regulates hematopoietic potential of pluripotent stem cells through integrin β1-ILK-β-catenin-JUN axis. Stem Cell Research. 2021. 53. 102287-102287
Akinori Yuzuriha, Sou Nakamura, Toshie Kusunoki, Takuya Matsumoto, Naoshi Sugimoto, Kiyotoshi Sekiguchi, Koji Eto. Environmental Cell-Matrix Adhesion Modulates Pluripotent Stem Cell Fate Toward Definitive Hemogenic Endothelium and Hematopoietic Progenitor Cells. BLOOD. 2018. 132

ｍore...

MISC (13)：

杠明憲, 江藤浩之. 【いま知っておきたい! 内科最新トピックス】(第3章)血液・造血器 iPS細胞による血液製剤. 内科. 2020. 126. 3. 461-463
杠明憲, 江藤浩之. 【疾患特異的iPS細胞を用いた病態研究と創薬】疾患特異的iPS細胞を用いた先天性血小板減少/異常症に対するアプローチ. 血液フロンティア. 2018. 28. 3. 379-385
杠明憲, 江藤浩之. 【再生医療と疾患解明の鍵となる組織幹細胞生体内の維持・分化制御からオルガノイド形成、がん・幹細胞疾患まで】(第2章)細胞-環境間シグナルからみた幹細胞の制御機構生命維持装置として登場した巨核球による造血幹細胞制御機構. 実験医学. 2016. 34. 17. 2844-2849
杠明憲, 江藤浩之. 【血小板の誕生と死】造血幹細胞から巨核球分化過程における最近の知見. 日本血栓止血学会誌. 2016. 27. 5. 519-525
杠明憲, 江藤浩之. iPS細胞を用いた再生医療による血小板輸血の現状と展望. 血液内科. 2015. 71. 4. 547-552

ｍore...

Patents (1)：

Method for producing hemogenic endothelial cell and/or hematopoietic progenitor cell from pluripotent stem cell

Lectures and oral presentations (9)：

高マグネシウム環境によって培養不死化赤芽球株のグロビン含有量は増加する.
(第22回日本再生医療学会総会. 2023)
Environment Cell Matrix Adhesion Modulates Pluripotent Stem Cell Fate toward Definitive Hemogenic Endothelium and Hematopoietic Progenitor Cells.
(60th ASH Annual Meeting & Exposition. 2018)
治療抵抗性のランゲルハンス細胞肉腫に対して同種造血幹細胞移植を実施し完全寛解を得た1例
(日本造血細胞移植学会総会プログラム・抄録集 2014)
進行性多巣性白質脳症を発症した再発びまん性大細胞型B細胞性リンパ腫
(日本リンパ網内系学会会誌 2014)
Lenalidomide治療中に上腸間膜静脈-門脈血栓塞栓症を発症し広範な壊死小腸切除を要した1例
(臨床血液 2014)

ｍore...

Education (2)：

2015 - 2020 Kyoto University Graduate School of Medicine Graduate School of Medicine
2001 - 2007 Gunma University Faculty of Medicine School of Medicine

Awards (1)：

2018 - American Society of Hematology ASH Abstract Achievement Award Environment Cell-Matrix Adhesion Modulates Pluripotent Stem Cell Fate toward Definitive Hemogenic Endothelium and Hematopoietic Progenitor Cells

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page